Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare genetic primary lymphedema characterized by lymphedema of all four limbs with age of onset ranging from birth to adulthood. Manifestations are of variable severity, and upper limb involvement may develop only later in the disease course. Recurrent episodes of cellulitis and skin infections are observed in severe cases. Varicose veins and venous incompetence have been reported in association.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for GJC2-related late-onset primary lymphedema.
3 publications have been identified in PubMed for GJC2-related late-onset primary lymphedema. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Basic Science / Preclinical (33%).
Brenner E (2025). [PMID: 41439975](https://pubmed.ncbi.nlm.nih.gov/41439975/). *Cells*. [Review / Meta-Analysis]
Chen J (2025). [PMID: 40678385](https://pubmed.ncbi.nlm.nih.gov/40678385/). *Front Genet*. [Case Report / Case Series]
Nelson-Maney NP (2024). [PMID: 38743922](https://pubmed.ncbi.nlm.nih.gov/38743922/). *J Clin Invest*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:44 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about GJC2-related late-onset primary lymphedema